Gershenson Elected Chair of Gynecologic Cancer Foundation
M. D. Anderson News Release 03/04/09
David Gershenson, M.D., professor and chair of the Department of Gynecologic Oncology at The University of Texas M. D. Anderson Cancer Center, has been tapped to lead the Gynecologic Cancer Foundation.
"It is a great honor to be elected chair of a national organization that's dedicated to advancing knowledge and progress against gynecologic cancers," Gershenson said. "While we've had successes against some types of these cancers, we must dedicate more research to others. I look forward to serving patients, survivors and all women through the foundation."
The Gynecologic Cancer Foundation (GCF) is a nonprofit organization established in 1991 by the Society of Gynecologic Oncologists. The foundation supports research and training in gynecologic cancers and promotes public awareness of prevention, early detection and treatment.
Through his study of rare forms of ovarian cancer, Gershenson has helped advance treatment and improve the quality of life for women. His contributions include finding targeted therapies for this disease, as well as treatments that retain the menstrual function and fertility of survivors.
In the upcoming months, Gershenson, with help from GCF staff members, hopes to expand the research program and find more opportunities to better serve the community.
Gershenson received his undergraduate degree from the University of Pennsylvania and medical degree from the Vanderbilt School of Medicine. After serving his internship with the University of Iowa Hospitals, he did his residency in obstetrics/gynecology at Yale-New Haven Hospital. Gershenson completed a two-year fellowship in gynecologic oncology at M. D. Anderson in 1979 and joined the faculty that same year.
During his career, Gershenson has been named one of the best doctors in America by Good Housekeeping, American Health, Castle Connolly's Guide and the Guide to America's Top Obstetricians and Gynecologists. He has edited six major textbooks on gynecology and published more than 320 peer-reviewed articles and 140 book chapters and invited articles.
Gershenson is editor emeritus of Gynecologic Oncology, having served as editor-in-chief from 1990 to 2008. He is former president of the Society of Gynecologic Oncologists, the American Radium Society, the Felix Rutledge Society, and the Houston Gynecological and Obstetrical Society. He is a fellow of the American College of Obstetricians and Gynecologists and of the American College of Surgeons and is chair of the Gynecologic Oncology Group's Rare Tumor Committee. In 2006, Gershenson was elected to a six-year term as a director of the American Board of Obstetrics and Gynecology and appointed to the National Cancer Institute's Gynecologic Cancer Steering Committee.